Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells

Role of microRNA-221/-222 in cancer development and progression

(2011) Tong Sun et al.   CELL CYCLE

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

(2010) Oskar W Rokhlin et al.   CANCER BIOLOGY & THERAPY

Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men

(2010) Christine M. Barnett et al.   CANCER CAUSES & CONTROL

Plasma 25-hydroxyvitamin D and prostate cancer risk: The Multiethnic Cohort

(2010) Song-Yi Park et al.   EUROPEAN JOURNAL OF CANCER

Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status

(2010) Sarah Mordan-McCombs et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Epigenetic control of a VDR-governed feed-forward loop that regulates p21 ( waf1/cip1 ) expression and function in non-malignant prostate cells

(2010) James L. Thorne et al.   NUCLEIC ACIDS RESEARCH

Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein

(2010) J Xiong et al.   ONCOGENE

The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex

(2010) Lakshmanane Boominathan   PLoS One

miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes

(2010) Xu-Bao Shi et al.   PROSTATE

Vitamin D for Cancer Prevention: Global Perspective

(2009) Cedric F. Garland et al.   ANNALS OF EPIDEMIOLOGY

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

(2009) Tao Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Insights into Ca2+ homeostasis of advanced prostate cancer cells

(2009) Matthieu Flourakis et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

(2009) André N. Vis et al.   BJU INTERNATIONAL

Vitamin D deficiency and insufficiency among patients with prostate cancer

(2009) Donald L. Trump et al.   BJU INTERNATIONAL

Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase

(2009) André N. Vis et al.   BJU INTERNATIONAL

Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk

(2009) Lu Yin et al.   Cancer Epidemiology

miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth

(2009) J. Ribas et al.   CANCER RESEARCH

ATP modulates Ca2+ uptake by TRPV6 and is counteracted by isoform-specific phosphorylation

(2009) Dalia Al-Ansary et al.   FASEB JOURNAL

MicroRNA regulates human vitamin D receptor

(2009) Takuya Mohri et al.   INTERNATIONAL JOURNAL OF CANCER

Expanding Roles of Vitamin D

(2009) Edward Giovannucci   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Protein Kinase C-Dependent Upregulation of miR-203 Induces the Differentiation of Human Keratinocytes

(2009) Enikö Sonkoly et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

(2008) S. Ambs et al.   CANCER RESEARCH

Effects of Iejimalide B, a marine macrolide, on growth and apoptosis in prostate cancer cell lines

(2008) Wei-Lin Winnie Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The vitamin D receptor in cancer

(2008) James Thorne et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Loss of mir-146a function in hormone-refractory prostate cancer

(2008) S.-L. Lin et al.   RNA

Non-genomic actions of androgens

(2007) C.D. Foradori et al.   FRONTIERS IN NEUROENDOCRINOLOGY